Want to see SE:ENZY full AI Analyst Report?
Enzymatica AB (ENZY) Ratios
Enzymatica AB Ratios
SE:ENZY's free cash flow for Q2 2026 was $-11.69M. For the 2026 fiscal year, SE:ENZY's free cash flow was decreased by $-1.00K and operating cash flow was $-11.69M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.65 | 6.28 | 1.20 | 3.14 | 2.09 |
| Quick Ratio | 2.59 | 5.34 | 0.84 | 2.72 | 1.69 |
| Cash Ratio | 1.86 | 4.22 | 0.26 | 1.88 | 1.02 |
| Solvency Ratio | -2.61 | -2.70 | -0.88 | -1.27 | -1.21 |
| Operating Cash Flow Ratio | -2.30 | -3.39 | -1.24 | -2.39 | -1.16 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -33.05 | 3.60 | -153.94 |
| Net Current Asset Value | $ 47.22M | $ 93.14M | $ -10.52M | $ 36.73M | $ 32.71M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.14 | 0.13 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.24 | 0.18 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.19 | 0.15 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.16 | 0.14 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.11 | 1.64 | 1.38 | 1.26 |
| Debt Service Coverage Ratio | -37.98 | -25.74 | -12.43 | 3.53 | -33.76 |
| Interest Coverage Ratio | -42.41 | -27.31 | -23.01 | -68.42 | -50.90 |
| Debt to Market Cap | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.11 | 0.14 | 0.02 |
| Net Debt to EBITDA | 0.69 | 1.48 | -0.24 | 0.47 | 0.76 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.45% | 67.40% | 62.59% | 58.13% | 58.26% |
| EBIT Margin | -96.86% | -112.85% | -93.57% | -138.41% | -78.28% |
| EBITDA Margin | -86.83% | -108.01% | -80.78% | -122.52% | -66.71% |
| Operating Profit Margin | -96.86% | -114.22% | -94.42% | -139.37% | -79.04% |
| Pretax Profit Margin | -96.17% | -117.03% | -97.67% | -140.45% | -79.84% |
| Net Profit Margin | -96.27% | -116.68% | -97.69% | -140.27% | -79.30% |
| Continuous Operations Profit Margin | -96.08% | -116.68% | -97.69% | -140.27% | -79.30% |
| Net Income Per EBT | 100.10% | 99.70% | 100.02% | 99.87% | 99.33% |
| EBT Per EBIT | 99.29% | 102.46% | 103.45% | 100.78% | 101.00% |
| Return on Assets (ROA) | -36.55% | -27.24% | -39.49% | -39.36% | -28.91% |
| Return on Equity (ROE) | -41.79% | -30.15% | -64.91% | -54.36% | -36.32% |
| Return on Capital Employed (ROCE) | -42.04% | -29.34% | -51.42% | -46.28% | -35.88% |
| Return on Invested Capital (ROIC) | -41.66% | -29.06% | -50.11% | -52.15% | -35.23% |
| Return on Tangible Assets | -66.70% | -41.21% | -86.36% | -66.29% | -55.32% |
| Earnings Yield | -11.25% | -17.46% | -7.67% | -9.89% | -3.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.07 | 3.36 | 4.08 | 2.96 | 3.04 |
| Payables Turnover | 2.37 | 1.51 | 2.58 | 3.07 | 3.14 |
| Inventory Turnover | 1.10 | 0.89 | 1.66 | 1.78 | 1.92 |
| Fixed Asset Turnover | 5.20 | 3.17 | 3.09 | 2.98 | 3.78 |
| Asset Turnover | 0.38 | 0.23 | 0.40 | 0.28 | 0.36 |
| Working Capital Turnover Ratio | 0.76 | 0.91 | 1.59 | 1.07 | 2.20 |
| Cash Conversion Cycle | 250.55 | 278.02 | 168.60 | 209.40 | 193.82 |
| Days of Sales Outstanding | 71.98 | 108.59 | 89.49 | 123.20 | 120.07 |
| Days of Inventory Outstanding | 332.27 | 410.50 | 220.43 | 205.01 | 190.04 |
| Days of Payables Outstanding | 153.71 | 241.07 | 141.32 | 118.81 | 116.29 |
| Operating Cycle | 404.25 | 519.09 | 309.91 | 328.21 | 310.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.17 | -0.31 | -0.23 | -0.39 | -0.24 |
| Free Cash Flow Per Share | -0.17 | -0.32 | -0.23 | -0.41 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | -177.37 | -153.96 | -55.19 | -17.37 | -5.85 |
| Capital Expenditure Coverage Ratio | -177.37 | -153.96 | -55.19 | -17.37 | -5.85 |
| Operating Cash Flow Coverage Ratio | -40.05 | -27.49 | -2.23 | -2.89 | -13.79 |
| Operating Cash Flow to Sales Ratio | -0.76 | -1.33 | -0.79 | -1.32 | -0.63 |
| Free Cash Flow Yield | -8.93% | -20.00% | -6.33% | -9.84% | -3.54% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.05 | -5.64 | -13.04 | -10.11 | -26.11 |
| Price-to-Sales (P/S) Ratio | 8.56 | 6.68 | 12.74 | 14.18 | 20.70 |
| Price-to-Book (P/B) Ratio | 3.71 | 1.73 | 8.46 | 5.50 | 9.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.19 | -5.00 | -15.81 | -10.17 | -28.22 |
| Price-to-Operating Cash Flow Ratio | -11.26 | -5.03 | -16.09 | -10.75 | -33.04 |
| Price-to-Earnings Growth (PEG) Ratio | 0.36 | 0.00 | 0.41 | -0.31 | -0.11 |
| Enterprise Value Multiple | -9.17 | -4.70 | -16.00 | -11.10 | -30.28 |
| Enterprise Value | 429.09M | 231.51M | 658.07M | 665.80M | 1.16B |
| EV to EBITDA | -9.17 | -4.70 | -16.00 | -11.10 | -30.28 |
| EV to Sales | 7.96 | 5.08 | 12.93 | 13.60 | 20.20 |
| EV to Free Cash Flow | -10.41 | -3.80 | -16.04 | -9.75 | -27.53 |
| EV to Operating Cash Flow | -10.47 | -3.83 | -16.33 | -10.31 | -32.23 |
| Tangible Book Value Per Share | 0.25 | 0.57 | 0.05 | 0.33 | 0.34 |
| Shareholders’ Equity Per Share | 0.51 | 0.92 | 0.43 | 0.76 | 0.85 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.00 | 0.01 |
| Revenue Per Share | 0.22 | 0.24 | 0.29 | 0.29 | 0.39 |
| Net Income Per Share | -0.21 | -0.28 | -0.28 | -0.41 | -0.31 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 |
| Interest Burden | 0.99 | 1.04 | 1.04 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.29 | 0.34 | 0.30 | 0.54 | 0.42 |
| SG&A to Revenue | 1.29 | 1.49 | 0.77 | 0.79 | 0.57 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 1.14 | 0.84 | 0.95 | 0.79 |
Currency in SEK